ASBMT Clinical Research Training Course 2015
In order to improve overall patient care, findings from the laboratory need to be better communicated to clinicians providing day-to-day patient care. Giving these clinicians access and understanding of the principles of research will help address this issue. This meeting, will fill-in the gap of the principles of research by offering formal presentation with extensive follow-up dialogue and small-group discussion.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and American Society for Blood and Marrow Transplantation (ASBMT) . The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
The Medical College of Wisconsin designates this live activity for a maximum of 17.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this activity for up to 17.00 hours of participation for continuing education for allied health professionals.
Objectives and Curriculum
- Research subject eligibility and recruitment
- Clinical trial design
- Biostatistics
- Data management and quality control
- Study endpoints
- Late effects and quality of life
- Clinical pharmacology, including polypharmacy and drug interactions
- Regulatory compliance
- Relationships with pharmaceutical companies and third-party payers
- Opportunities for grants and clinical research training
- Grant writing
- Working with a mentor
- Translational trials
- Working with laboratory investigators
- Research ethics
- Subject safety
This educational activity is being supported by Millennium Pharmaceuticals, Seattle Genetics, Merck, Otsuka America Pharmaceutical, Jazz Pharmaceutical, and Amgen Inc.
Target Audience
Physicians and allied health professionals
Learning Objectives
At the conclusion of this activity, scholars should be able to:
- Understand the fundamentals of clinical trial design, implementation (regulations) and monitoring
- Effectively present original research in preparation for presentations at national/international meetings
- Address questions relating to original research
- Critically analyze presented clinical research studies
- Establish professional and personal networks for collaborations
- Address the next step(s) in SCT career path
Planning Committee:
Christopher N. Bredeson, MD, MSc
Catherine Bollard, MD
Name | Company | Role |
Catherine Bollard, MD | Cellmedica | `Speaker |
Christopher Bredeson, MD, MSc | Celgene | Ad Board, Research, Out Reach |
Otsuka | Advisory Board | |
Sanofi | Advisory Board | |
Brenda Sandmaier, MD | Gilead | Spouse |
EpiThany; Blaze | Spouse | |
ArevaMed; Jazz Pharmaceutical | Advisory Board |
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following and in accordance with the ACCME® standards for Commercial Support Number 6, these relationships were reviewed via the MCW conflict of interest resolution process and resolved.
Available Credit
- 17.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 17.00 Hours of ParticipationHours of Participation credit.